Molecular Data Inc. American Depositary Shares
MKD was delisted on the 6th of September, 2022.
3 hedge funds and large institutions have $6.26M invested in Molecular Data Inc. American Depositary Shares in 2020 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
69,411% more capital invested
Capital invested by funds: $9K → $6.26M (+$6.25M)
200% more funds holding
Funds holding: 1 → 3 (+2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SNN
Shen Neil Nanpeng
|
+$9.01M |
| 2 |
HF
HRT Financial
New York
|
+$48.6K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$2.11K |
Top Sellers
MKD Hedge Fund Activity: Q3 2020 in Review
3 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Molecular Data Inc. American Depositary Shares (MKD) for Q3 2020, worth a combined $6.26M — up 69,411% from $9K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new MKD positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Shen Neil Nanpeng, opening a new position worth an estimated $9.01M.
- 3 institutional investors held Molecular Data Inc. American Depositary Shares (MKD) as of Q3 2020, up from 1 in Q2 2020.
- Funds reported $6.26M of Molecular Data Inc. American Depositary Shares stock for Q3 2020, up 69,411% quarter-over-quarter.
- 2 funds opened new Molecular Data Inc. American Depositary Shares positions in Q3 2020 and 0 closed out, a net change of +2 holders.
- The largest Molecular Data Inc. American Depositary Shares buyer in Q3 2020 was Shen Neil Nanpeng, an estimated $9.01M added.
Based on aggregated 13F filings for Q3 2020.